Image source: The Motley Fool.
Karyopharm Therapeutics (NASDAQ: KPTI)
Q2 2022 Earnings Call
Aug 04, 2022 , 8:00 a.m. ET
Operator
For further details see:
Karyopharm Therapeutics (KPTI) Q2 2022 Earnings Call TranscriptImage source: The Motley Fool.
Karyopharm Therapeutics (NASDAQ: KPTI)
Q2 2022 Earnings Call
Aug 04, 2022 , 8:00 a.m. ET
Operator
For further details see:
Karyopharm Therapeutics (KPTI) Q2 2022 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Karyopharm Therapeutics Inc. Company Name:
KPTI Stock Symbol:
Market:
Karyopharm Therapeutics Inc. Website:
Karyopharm to Participate at Barclays 26th Annual Global Healthcare and Leerink Partners Global Biopharma Conferences PR Newswire NEWTON, Mass. , March 6, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company ...
2024-02-29 18:15:15 ET Image source: The Motley Fool. Karyopharm Therapeutics (NASDAQ: KPTI) Q4 2023 Earnings Call Feb 29, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Karyopharm Therapeutics (KPTI) Q4 2023 Earnings C...
Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress PR Newswire – Total Revenue of $146 Million and U.S. XPOVIO® (selinexor) Net Product Revenue of $112 Million for Full Year 2023, Meeting Co...